A new study examines how cost, side effects, and other factors influence whether people stop GLP-1s, while Noom cuts staff to ...
CagriSema combines semaglutide, the active ingredient in Wegovy, with a molecule that mimics a pancreatic hormone.
Is compounded semaglutide effective for weight loss? Here’s the short version: Compounded semaglutide isn’t approved by the ...
New research reveals Ozempic users may face twice the risk of developing a rare but irreversible form of vision loss. Danish ...
Investors are upset at a lack of clarity over the results of Wegovy successor CagriSema after trials published in December.
Physician–scientists at the University of Utah's John A. Moran Eye Center have published an investigatory review of nine ...
Pharma giant Novo Nordisk, the company behind Wegovy and Ozempic, expects to launch six products in the next five years. Leading the pack of new drugs will be CagriSema.
Experts are calling on the government to implement strategies that will better predict future Ozempic shortages.
The AP-NORC survey shows about half of U.S. adults believe it is a good thing for adults to use Ozempic, Wegovy and similar ...
As warnings are issued over weight loss medication being too easy to buy online, here is one cautionary tale of how it can be ...
One in ten people in the UK have a needle phobia so serious it means they frequently miss out on vital treatments such as ...
The pharmacy regulator is working with other bodies to jointly tackle inappropriate advertising and promotions of the drugs ...